Pressure BioSciences Finalizes All-Stock Buyout of Uncle Bud's, Expands Market Presence with UltraShear Technology

SOUTH EASTON, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. OTCQB: PBIO, a company that has established itself as a leader in the design, development, and commercialization of innovative pressure-based solutions for the global life sciences industry, has made a significant stride in the market with the acquisition of Uncle Bud's. The transaction was completed entirely in stock, paving the way for Pressure BioSciences to integrate its patented UltraShear platform with Uncle Bud's established marketing and sales channels globally.

Strategic Significance of the Acquisition

The acquisition of Uncle Bud's by Pressure BioSciences is seen as a forward integration that promises to unify the game-changing UltraShear technology for creating stable nanoemulsions—a process beneficial in numerous industries—with a formidable marketing and sales team experienced in delivering products to consumers. The all-stock nature of the deal underscores the value that Pressure BioSciences places on Uncle Bud's capabilities and market penetration, signifying an optimistic future outlook for the combined entity.

Focusing on UltraShear Technology

UltraShear technology is a proprietary method developed by Pressure BioSciences that harnesses ultra-high pressure conditions to produce high-quality, stable nanoemulsions. The merging with Uncle Bud's is anticipated to provide not only an expanded reach for this technology but also ensures that the path to market for products utilizing UltraShear is smoothed and efficiencized, a synergy that could yield remarkable results within the business landscape.

Market Impact and Future Outlook

With the successful closure of the Uncle Bud's acquisition, Pressure BioSciences is well-positioned to capitalize on the burgeoning demand for nanoemulsion-based products. The company is now equipped with a robust sales and marketing wing, which is expected to expedite the commercialization of its next-generation technologies. As Pressure BioSciences continues to drive innovation and expand its market reach, the industry watches closely to see how this strategic move will shape the future of nanoemulsion applications and Pressure BioSciences' growth trajectory.

Acquisition, Innovation, Integration